Medical Weight Loss for Rochester, New York Residents

Rochester, New York residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Rochester through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Same physician, wherever you live in New York: patients in Rochester see the same Dr. Sharma and the same protocol as our Costa Mesa, California patients, just delivered by telehealth instead of in person. Results vary. Doctor review just $119 (medication separate).

Why Rochester Residents Choose New Hope Weight Loss

New Hope keeps the money part simple so you can focus on the health part. For Rochester patients that means semaglutide from $166 monthly, tirzepatide from $233 monthly, a $119 physician visit, no insurance required, and no penalty for living outside Costa Mesa. We take HSA, FSA, Klarna, and Affirm, so paying out of pocket does not have to mean paying all at once. Clear terms, no games.

From our Costa Mesa, California practice, we provide Rochester with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

Living in Rochester, New York means your weight-loss care comes to you online rather than the other way around, with Dr. Anjmun Sharma supervising each step from our Costa Mesa practice. We care for patients throughout Downtown, the East End, Park Avenue, and the greater Finger Lakes region. Our team supports you in English and Spanish, so you can ask questions in the language you are most comfortable with no matter where in Rochester you are.

Treatment is supervised by the same physician for all of New York, which means your distance from Costa Mesa changes nothing about your care or your cost. The $119 fee covers the physician review and visit itself; the medication, whether semaglutide from $166 a month or tirzepatide from $233, is a separate charge. New York is among the most populous states in the nation, and New Hope Weight Loss serves patients across it, from the city to upstate, by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Compounded GLP-1 care, supervised by a physician

The 90-Day Metabolic Reset is built on semaglutide, the same active ingredient you will find in Wegovy and Ozempic. It is priced from $166/mo, with the complete 90-day program at $499, and branded-drug trials averaged about 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved, not brand-identical, and results vary by person. Dr. Sharma manages your care by telehealth, wherever you are in Rochester.

Prefer the dual-action route? Tirzepatide

From $233/mo, tirzepatide works on GLP-1 and GIP together. In branded-drug trials, dose-qualified patients reached up to 22.5 percent loss, a peak number that is not typical. Same active ingredient as Mounjaro and Zepbound.

It all starts with a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Rochester

Here is how the whole thing works, start to finish, for anyone in Rochester.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Rochester address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Rochester

Where is the closest New Hope Weight Loss to Rochester?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Rochester, New York patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Rochester?

It is not. We run a complete telehealth model, so people in Rochester handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Rochester using cold-pack insulation that keeps it stable until it reaches you.

What should a Rochester patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Rochester patients are not charged any extra distance fee.

What areas of Rochester do you serve?

We serve patients from across Rochester by telehealth, including Downtown, the East End, Park Avenue, and the greater Finger Lakes region.

Who qualifies for the program in Rochester?

Eligibility for Rochester patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Rochester Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Rochester, New York by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.